| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 715755 | Null | 0.0217366743178497 | 0.30586378 |
| NSC 720174 | Null | 0.0217366743178497 | -0.063317845 |
| NSC 722222 | Null | 0.0217366743178497 | 0.38571841 |
| NSC 722341 | 2-(3'-Hydroxy-3'-methylbut-1'-ynyl)-4,6-di-(4''-methoxypheno xy)-1,3,5-triazine | 0.0217366743178497 | 0.43838248 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0217366743178497 | 0.60200226 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0217366743178497 | 0.018359484 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0217366743178497 | 0.44578098 |
| NSC 741942 | Null | 0.0217366743178497 | 0.47636858 |
| NSC 749379 | Null | 0.0217366743178497 | 0.48581161 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0217366743178497 | 0.480421 |